Redmont Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$10.5K Hold
32
0.02% 179
2025
Q3
$9.03K Hold
32
0.01% 199
2025
Q2
$8.94K Buy
+32
New +$9.06K 0.01% 194
2024
Q4
Sell
-72
Closed -$23.2K 77
2024
Q3
$23.2K Hold
72
0.04% 126
2024
Q2
$22.5K Hold
72
0.04% 125
2024
Q1
$20.5K Buy
+72
New +$21.1K 0.03% 146
2023
Q1
Sell
-1,040
Closed -$273K 64
2022
Q4
$273K Hold
1,040
0.32% 81
2022
Q3
$234K Hold
1,040
0.3% 81
2022
Q2
$253K Hold
1,040
0.31% 81
2022
Q1
$251K Buy
1,040
+40
+4% +$9.19K 0.27% 84
2021
Q4
$225K Buy
+1,000
New +$211K 0.24% 101

Other funds holding AMGN

Redmont Wealth Advisors's AMGN Position: Q4 2025 in Review

Redmont Wealth Advisors held its Amgen (AMGN) position steady in Q4 2025 at 32 shares worth $10.5K. The position accounts for 0.02% of the portfolio, ranked #179.

Redmont Wealth Advisors first reported a position in AMGN in Q4 2021 and has held it in 11 quarters since. The position peaked at $273K in Q4 2022. 3,094 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Redmont Wealth Advisors held 32 shares of Amgen worth $10.5K as of Q4 2025.
  • Redmont Wealth Advisors left its Amgen share count unchanged in Q4 2025.
  • Amgen made up 0.02% of Redmont Wealth Advisors's portfolio in Q4 2025, its #179 holding.
  • Redmont Wealth Advisors first reported a position in Amgen in Q4 2021 and has held it in 11 quarters since.
  • Redmont Wealth Advisors's Amgen position peaked at $273K in Q4 2022.
  • 3,094 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Redmont Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.